门诊全肩关节置换术:当前趋势、并发症、再入院和费用的综合分析
本研究利用美国全国保险数据库,分析2010年第四季度至2014年间接受解剖型全肩关节置换术的患者,比较门诊与匹配的住院全肩关节置换术患者在并发症、再入院和费用方面的差异。结果显示门诊全肩关节置换术年发病率翻倍,并发症和再入院率与住院组无显著差异,且费用显著更低。作者认为在适当选择的患者中,门诊全肩关节置换术是可行且安全的实践模式。
要点
- 2010年第四季度至2014年,门诊全肩关节置换术的年发病率翻倍。
- 门诊全肩关节置换术患者并发症发生率与匹配住院组相比无显著升高。
- 门诊全肩关节置换术患者再入院率与住院组无显著差异(p > 0.05)。
核心结论
- 作者认为,在适当选择的患者中,门诊全肩关节置换术是可行且安全的实践模式。
- 与匹配的住院患者相比,门诊全肩关节置换术也显著节省费用。
研究设计与样本
- 查询全国保险数据库,纳入2010年第四季度至2014年间接受解剖型全肩关节置换术的患者。
- 识别接受门诊全肩关节置换术的患者(706例)和匹配的住院全肩关节置换术患者(4,459例)。
主要发现
- 从2010年第四季度至2014年,门诊全肩关节置换术的年发病率翻倍。
- 门诊全肩关节置换术患者中,没有任何并发症的发生率显著高于住院患者。
- 两队列间再入院率无显著差异(p > 0.05)。
- 门诊全肩关节置换术患者费用为14,722美元,显著低于匹配对照组的18,336美元(p < 0.0001),涉及多个分项费用类别以及诊断相关组相关费用。
临床怎么用
- 作者认为,在适当选择的患者中,门诊全肩关节置换术是可行且安全的实践模式,并且与住院全肩关节置换术相比可显著节省费用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There have been few studies that have evaluated ambulatory total shoulder arthroplasty. The objectives of the present study were to investigate the current trends in ambulatory total shoulder arthroplasty in the United States; to characterize the rate of postoperative complications, hospital readmission, and risk factors associated with readmission; and to conduct a cost analysis comparing ambulatory total shoulder arthroplasty with matched inpatient total shoulder arthroplasty. METHODS: A national insurance database was queried for patients who underwent anatomic total shoulder arthroplasty between the fourth quarter of 2010 and 2014. Patients undergoing ambulatory total shoulder arthroplasty and a matched group of patients undergoing inpatient total shoulder arthroplasty were identified. Complications were assessed for both groups. Risk factors for readmission within 90 days postoperatively were examined. The costs up to 30 days postoperatively were evaluated for patients who underwent ambulatory total shoulder arthroplasty and controls. RESULTS: Included in the study were 706 patients who underwent ambulatory total shoulder arthroplasty. From the fourth quarter of 2010 to 2014, the yearly incidence of ambulatory total shoulder arthroplasty doubled. In the study, 4,459 patients who underwent inpatient total shoulder arthroplasty were matched to patients who underwent ambulatory total shoulder arthroplasty. In no instances were any complications present at a significantly higher rate in the patients who underwent ambulatory total shoulder arthroplasty. The rate of readmission was not significantly different (p > 0.05) between the 2 cohorts. The patients undergoing ambulatory total shoulder arthroplasty had significantly lower costs (p < 0.0001) at $14,722 compared with the matched controls at $18,336 in numerous itemized cost categories as well as costs related to diagnosis-related groups. CONCLUSIONS: In appropriately selected patients, ambulatory total shoulder arthroplasty is a viable and safe practice model. Ambulatory total shoulder arthroplasty also offers significant cost savings compared with inpatient total shoulder arthroplasty in matched patients. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Cancienne JM, Brockmeier SF, Gulotta LV, et al. Ambulatory Total Shoulder Arthroplasty: A Comprehensive Analysis of Current Trends, Complications, Readmissions, and Costs. J Bone Joint Surg Am. 2017. PMID: 28419030. doi:10.2106/JBJS.16.00287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。